{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:35:57Z","timestamp":1789785357126,"version":"4.0.1"},"reference-count":48,"publisher":"Walter de Gruyter GmbH","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1,26]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background:<\/jats:title><jats:p>Growth prediction models (GPMs) exist to support clinical management of children treated with growth hormone (GH) for growth hormone deficiency (GHD), Turner syndrome (TS) and for short children born small for gestational age (SGA). Currently, no prediction system has been widely adopted.<\/jats:p><\/jats:sec><jats:sec><jats:title>Content:<\/jats:title><jats:p>The objective was to develop a stand-alone web-based system to enable the widespread use of an \u2018individualised growth response optimisation\u2019 (iGRO) tool across European endocrinology clinics. A modern platform was developed to ensure compatibility with IT systems and web browsers. Seventeen GPMs derived from the KIGS database were included and tested for accuracy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Summary:<\/jats:title><jats:p>The iGRO system demonstrated prediction accuracy and IT compatibility. The observed discrepancies between actual and predicted height may support clinicians in investigating the reasons for deviations around the expected growth and optimise treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>This system has the potential for wide access in endocrinology clinics to support the clinical management of children treated with GH for these three indications.<\/jats:p><\/jats:sec>","DOI":"10.1515\/jpem-2017-0120","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T10:01:08Z","timestamp":1505296868000},"source":"Crossref","is-referenced-by-count":23,"title":["Individualised growth response optimisation (iGRO) tool: an accessible and easy-to-use growth prediction system to enable treatment optimisation for children treated with growth hormone"],"prefix":"10.1515","volume":"30","author":[{"given":"Jane","family":"Loftus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferah","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Maghnie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoul","family":"Rooman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Steinkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmuth","family":"Doerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ranke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Camacho-Hubner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","reference":[{"key":"ref51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000347121","article-title":"Towards optimal treatment with growth hormone in short children and adolescents: evidence and theses","volume":"79","year":"2013","journal-title":"Horm Res Paediatr"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1515\/jpem-2000-s609","article-title":"New paradigms for growth hormone treatment in the 21st century: prediction models","volume":"13","year":"2000","journal-title":"J Paed Endocrinol Metab"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1472-6947-11-38","article-title":"Prediction models for short children born small for gestational age (SGA) covering the total growth phase. Analyses based on data from KIGS (Pharmacia International Growth Database)","volume":"11","year":"2011","journal-title":"BMC Med Inform Decis Mak"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ghir.2008.08.001","article-title":"Predicting growth in response to growth hormone treatment","volume":"19","year":"2009","journal-title":"Growth Horm IGF Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1651-2227.1999.tb14356.x","article-title":"Final height in idiopathic growth hormone deficiency: the KIGS experience. KIGS International Board","volume":"88","year":"1999","journal-title":"Acta Paediatr Suppl"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1210\/jc.2007-0900","article-title":"Growth hormone therapy in childhood: titration versus weight-based dosing?","volume":"92","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000184843","article-title":"Some questions about how growth standards are used","volume":"45","year":"1996","journal-title":"Horm Res"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1472-6947-11-38","article-title":"Prediction models for short children born small for gestational age (SGA) covering the total growth phase. Analyses based on data from KIGS (Pharmacia International Growth Database)","volume":"11","year":"2011","journal-title":"BMC Med Inform Decis Mak"},{"key":"ref531","first-page":"e16233","article-title":"Non-adherence with growth hormone treatment in children is common and impairs linear growth","volume":"6","year":"2011","journal-title":"PLoS One"},{"key":"ref121","first-page":"13","article-title":"A new and accurate prediction model for growth response to growth hormone treatment in children with growth hormone deficiency","volume":"144","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1210\/jc.2003-030600","article-title":"The mathematical model for total pubertal growth in idiopathic growth hormone (GH) deficiency suggests a moderate role of GH dose","volume":"88","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1203\/01.pdr.0000250039.42000.c9","article-title":"on behalf of the KIGS international board. Major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGS","volume":"61","year":"2007","journal-title":"Paediatr Res"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1210\/jc.2003-030600","article-title":"The mathematical model for total pubertal growth in idiopathic growth hormone (GH) deficiency suggests a moderate role of GH dose","volume":"88","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"ref91","first-page":"501","article-title":"Predicting the growth response of children with idiopathic growth hormone deficiency to one year of recombinant growth hormone treatment: derivation and validation of a useful method","volume":"22","year":"2009","journal-title":"J Paed Endocrinol Metab"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/cen.12014","article-title":"American norditropin study group. Efficacy of IGF-based growth hormone (GH) dosing in non GH-deficient (non GHD) short stature children with low IGF-I is not related to basal IGF-I levels","volume":"78","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000347121","article-title":"Towards optimal treatment with growth hormone in short children and adolescents: evidence and theses","volume":"79","year":"2013","journal-title":"Horm Res Paediatr"},{"key":"ref401","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1203\/00006450-200010000-00010","article-title":"Validated multivariate models predicting the growth response to GH treatment in individual short children with a broad range in GH secretion capacities","volume":"48","year":"2000","journal-title":"Paediatr Res"},{"key":"ref361","first-page":"501","article-title":"Predicting the growth response of children with idiopathic growth hormone deficiency to one year of recombinant growth hormone treatment: derivation and validation of a useful method","volume":"22","year":"2009","journal-title":"J Paed Endocrinol Metab"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000351025","article-title":"Personalized approach to growth hormone treatment: clinical use of growth prediction models","volume":"79","year":"2013","journal-title":"Horm Res Paediatr"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s40258-013-0030-4","article-title":"Implications of a data-driven approach to treatment with growth hormone in children with growth hormone deficiency and Turner syndrome","volume":"11","year":"2013","journal-title":"Appl Health Econ Health Policy"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ghir.2008.08.001","article-title":"Predicting growth in response to growth hormone treatment","volume":"19","year":"2009","journal-title":"Growth Horm IGF Res"},{"key":"ref281","first-page":"96","article-title":"Controversies in the diagnosis and management of growth hormone deficiency in childhood and adolescence","volume":"101","year":"2015","journal-title":"Arch Dis Child"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1651-2227.1999.tb14356.x","article-title":"Final height in idiopathic growth hormone deficiency: the KIGS experience. KIGS International Board","volume":"88","year":"1999","journal-title":"Acta Paediatr Suppl"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jcem.84.4.5634","article-title":"Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS international board kabi pharmacia international growth study","volume":"84","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1203\/00006450-200010000-00010","article-title":"Validated multivariate models predicting the growth response to GH treatment in individual short children with a broad range in GH secretion capacities","volume":"48","year":"2000","journal-title":"Paediatr Res"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jcem.84.4.5634","article-title":"Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS international board kabi pharmacia international growth study","volume":"84","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1515\/jpem-2000-s608","article-title":"Evidence-based growth hormone therapy prediction models","volume":"13","year":"2000","journal-title":"J Paed Endocrinol Metab"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1210\/jc.2002-020867","article-title":"Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database)","volume":"88","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1440-1754.1996.tb00901.x","article-title":"Growth hormone therapy for 3 years: the OZGROW experience","volume":"32","year":"1996","journal-title":"J Paed Child Health"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1210\/jcem.85.11.6976","article-title":"Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. KIGS International Board, Kabi International Growth Study","volume":"85","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"ref511","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1203\/01.pdr.0000250039.42000.c9","article-title":"on behalf of the KIGS international board. Major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGS","volume":"61","year":"2007","journal-title":"Paediatr Res"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1472-6947-11-38","article-title":"On behalf of the KIGS International Board. Prediction models for short children born small for gestational age (SGA) covering the total growth phase. Analyses based on data from KIGS (Pfizer International Growth Database)","volume":"11","year":"2011","journal-title":"BMC Med Inform Decis Mak"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000351025","article-title":"Personalized approach to growth hormone treatment: clinical use of growth prediction models","volume":"79","year":"2013","journal-title":"Horm Res Paediatr"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1210\/jc.2007-0900","article-title":"Growth hormone therapy in childhood: titration versus weight-based dosing?","volume":"92","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"ref11","first-page":"96","article-title":"Controversies in the diagnosis and management of growth hormone deficiency in childhood and adolescence","volume":"101","year":"2015","journal-title":"Arch Dis Child"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/cen.12014","article-title":"American norditropin study group. Efficacy of IGF-based growth hormone (GH) dosing in non GH-deficient (non GHD) short stature children with low IGF-I is not related to basal IGF-I levels","volume":"78","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1515\/jpem-2000-s609","article-title":"New paradigms for growth hormone treatment in the 21st century: prediction models","volume":"13","year":"2000","journal-title":"J Paed Endocrinol Metab"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1210\/jc.2002-020867","article-title":"Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database)","volume":"88","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"ref261","first-page":"e16233","article-title":"Non-adherence with growth hormone treatment in children is common and impairs linear growth","volume":"6","year":"2011","journal-title":"PLoS One"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1210\/jcem.85.11.6976","article-title":"Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. KIGS International Board, Kabi International Growth Study","volume":"85","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s40258-013-0030-4","article-title":"Implications of a data-driven approach to treatment with growth hormone in children with growth hormone deficiency and Turner syndrome","volume":"11","year":"2013","journal-title":"Appl Health Econ Health Policy"},{"key":"ref391","first-page":"13","article-title":"A new and accurate prediction model for growth response to growth hormone treatment in children with growth hormone deficiency","volume":"144","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"ref81","first-page":"685","article-title":"Predicting the growth response to growth hormone (GH) treatment in prepubertal and pubertal children with isolated GH deficiency \u2013 model validation in an observational setting (GeNeSIS)","volume":"20","year":"2007","journal-title":"J Paed Endocrinol Metab"},{"key":"ref481","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1440-1754.1996.tb00901.x","article-title":"Growth hormone therapy for 3 years: the OZGROW experience","volume":"32","year":"1996","journal-title":"J Paed Child Health"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000184843","article-title":"Some questions about how growth standards are used","volume":"45","year":"1996","journal-title":"Horm Res"},{"key":"ref521","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1472-6947-11-38","article-title":"On behalf of the KIGS International Board. Prediction models for short children born small for gestational age (SGA) covering the total growth phase. Analyses based on data from KIGS (Pfizer International Growth Database)","volume":"11","year":"2011","journal-title":"BMC Med Inform Decis Mak"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1515\/jpem-2000-s608","article-title":"Evidence-based growth hormone therapy prediction models","volume":"13","year":"2000","journal-title":"J Paed Endocrinol Metab"},{"key":"ref351","first-page":"685","article-title":"Predicting the growth response to growth hormone (GH) treatment in prepubertal and pubertal children with isolated GH deficiency \u2013 model validation in an observational setting (GeNeSIS)","volume":"20","year":"2007","journal-title":"J Paed Endocrinol Metab"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/jpem.2017.30.issue-10\/jpem-2017-0120\/jpem-2017-0120.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2017-0120\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T19:56:09Z","timestamp":1659470169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2017-0120\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,1]]},"references-count":48,"journal-issue":{"issue":"10"},"URL":"https:\/\/doi.org\/10.1515\/jpem-2017-0120","relation":{},"ISSN":["2191-0251","0334-018X"],"issn-type":[{"value":"2191-0251","type":"electronic"},{"value":"0334-018X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1,1]]}}}